SCHEMBL27190087

SCHEMBL27190087

O=[N+]([O-])c1cc(Br)c2cccnc2c1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.78
MAPT P10636 9/20 0.78
MEN1 O00255 8/20 0.78
KMT2A Q03164 8/20 0.78
ALDH1A1 P00352 8/20 0.78
CTSB P07858 5/20 0.78
IDO1 P14902 2/20 0.78
TDO2 P48775 2/20 0.78
GAA P10253 2/20 0.78
TDP1 Q9NUW8 6/20 0.70
HTT P42858 6/20 0.70
L3MBTL1 Q9Y468 6/20 0.70
SMN1; SMN2 Q16637 6/20 0.70
LMNA P02545 5/20 0.70
PKM P14618 3/20 0.70
POLB P06746 3/20 0.70
RECQL P46063 2/20 0.70
BLM P54132 2/20 0.70
CASP6 P55212 2/20 0.70
THRB P10828 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10520193 0.88 KDM4E (0.78) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL18300579 0.88 MAPT (1.00) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL8164006 0.88 MAPT (1.00) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL18979856 0.85 MAPT (0.55) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL9201362 0.84 CTSB (0.56) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL7960630 0.83 MAPT (0.79) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL24716103 0.82 MAPT (0.78) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL9201355 0.82 MAPT (0.52) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL2111476 0.82 MAPT (1.00) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL27190082 0.82 MAPT (1.00) KDM4EMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 KDM4E 2921/4885MAPT 4416/4885MEN1 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.